The ETF That Has Something For Everyone
Of the exchange-traded fund highlighted in today’s article, the author declares that “Quite simply, this is a fund that has a place in just about…
The Straddle Strategy For Creating Stock Targets
When setting up your trades, how do you go about determining your exit target? The author of today’s article advises that “While using the charts…
Dividend Champions: Screening For The Cream Of The Crop
Not all dividend champions are created equal. In order to identify dividend champions worthy of further research, the author of today’s article screened the list…
3 Stocks Set For Decades Of Growth
When it comes to growth investors, the authors of today’s article state “We want high-quality growth stocks in our portfolios that can stand the test…
Why This Analyst Is Not High On Cannabis Funds – And Investors May Want To Avoid Most Of Them
When it comes to the relatively recent advent of mutual funds and exchange-traded funds focused on the cannabis industry, the author of today’s article states,…
Screening For ‘Buy The Dip’ Candidates – And 4 Stocks To Consider
Buying the dips is a popular – and lucrative – strategy where the key is identifying stocks that are in short-term down trends within long-term…
Ideas – And Concerns – From The Strategic Investment Conference 2018
At the Strategic Investment Conference 2018, some of the greatest minds in the investment community shared their thoughts on the economy, the markets – and…
Why Closed-End Funds Might Be “A Dream Come True” For Intrinsic Value Investors Right Now
The two keys behaviors of successful long-term investors, according to the author of today’s article, is that “they pick investments that are likely to provide…
Checking In On Gold And Resource Companies: Which Might Be Strong Buys?
In today’s article, the author examines recent developments at a number of gold and resource companies – and what those developments indicate about the attractiveness…
3 Biotech Stocks With Powerful Catalysts – Including A Potential Acquisition Target
The biotech sector outperformed the S&P 500 last year – and further strong performance could lie ahead thanks in part to the tax break for…